Connection

GEORGE JACKSON to Animals

This is a "connection" page, showing publications GEORGE JACKSON has written about Animals.
Connection Strength

0.490
  1. SCA31 Flies Perform in a Balancing Act between RAN Translation and RNA-Binding Proteins. Neuron. 2017 04 05; 94(1):4-5.
    View in: PubMed
    Score: 0.032
  2. Learn to forget: regulation of age-related memory impairment by neuronal-glial crosstalk. Neuron. 2014 Nov 19; 84(4):658-9.
    View in: PubMed
    Score: 0.027
  3. Evidence for autophagic gridlock in aging and neurodegeneration. Transl Res. 2014 Jul; 164(1):1-12.
    View in: PubMed
    Score: 0.026
  4. Interactions between Tau and a-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease. Hum Mol Genet. 2014 Jun 01; 23(11):3008-23.
    View in: PubMed
    Score: 0.026
  5. TDP-43 Phosphorylation by casein kinase Ie promotes oligomerization and enhances toxicity in vivo. Hum Mol Genet. 2014 Feb 15; 23(4):1025-35.
    View in: PubMed
    Score: 0.025
  6. The downward spiral of tau and autolysosomes: a new hypothesis in neurodegeneration. Autophagy. 2012 Jul 01; 8(7):1144-5.
    View in: PubMed
    Score: 0.023
  7. Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation. Hum Mol Genet. 2011 Dec 15; 20(24):4947-77.
    View in: PubMed
    Score: 0.022
  8. Demise of the flies: why Drosophila models still matter. Prog Mol Biol Transl Sci. 2011; 100:483-98.
    View in: PubMed
    Score: 0.021
  9. Interaction between eye pigment genes and tau-induced neurodegeneration in Drosophila melanogaster. Genetics. 2010 Sep; 186(1):435-42.
    View in: PubMed
    Score: 0.020
  10. Neurodegenerative models in Drosophila: polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis. Neurobiol Dis. 2010 Oct; 40(1):29-39.
    View in: PubMed
    Score: 0.020
  11. Emerging subspecialties in neurology: translational research in movement disorders. Neurology. 2009 Aug 25; 73(8):e40-1.
    View in: PubMed
    Score: 0.019
  12. Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model. Hum Mol Genet. 2009 Jan 01; 18(1):164-77.
    View in: PubMed
    Score: 0.018
  13. A Drosophila model of ALS: human ALS-associated mutation in VAP33A suggests a dominant negative mechanism. PLoS One. 2008 Jun 04; 3(6):e2334.
    View in: PubMed
    Score: 0.017
  14. Guide to understanding Drosophila models of neurodegenerative diseases. PLoS Biol. 2008 Feb; 6(2):e53.
    View in: PubMed
    Score: 0.017
  15. A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine. J Neurosci. 2007 Jan 31; 27(5):981-92.
    View in: PubMed
    Score: 0.016
  16. A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration. Neuron. 2006 Sep 07; 51(5):549-60.
    View in: PubMed
    Score: 0.015
  17. Drosophila models of neurodegenerative disease. NeuroRx. 2005 Jul; 2(3):438-46.
    View in: PubMed
    Score: 0.014
  18. Inactivation of Drosophila Apaf-1 related killer suppresses formation of polyglutamine aggregates and blocks polyglutamine pathogenesis. Hum Mol Genet. 2005 Feb 01; 14(3):357-72.
    View in: PubMed
    Score: 0.014
  19. Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron. 2002 May 16; 34(4):509-19.
    View in: PubMed
    Score: 0.011
  20. Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective. Prog Neurobiol. 2020 01; 184:101716.
    View in: PubMed
    Score: 0.010
  21. Uncoupling neuronal death and dysfunction in Drosophila models of neurodegenerative disease. Acta Neuropathol Commun. 2016 06 23; 4(1):62.
    View in: PubMed
    Score: 0.008
  22. Quantitative Assessment of Eye Phenotypes for Functional Genetic Studies Using Drosophila melanogaster. G3 (Bethesda). 2016 05 03; 6(5):1427-37.
    View in: PubMed
    Score: 0.007
  23. Amyloid-? oligomers as a template for secondary amyloidosis in Alzheimer's disease. Neurobiol Dis. 2014 Nov; 71:14-23.
    View in: PubMed
    Score: 0.007
  24. The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes. Acta Neuropathol Commun. 2014 May 29; 2:56.
    View in: PubMed
    Score: 0.007
  25. Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles. J Neurosci. 2014 Mar 19; 34(12):4260-72.
    View in: PubMed
    Score: 0.006
  26. Disruption of glycerol metabolism by RNAi targeting of genes encoding glycerol kinase results in a range of phenotype severity in Drosophila. PLoS One. 2013; 8(9):e71664.
    View in: PubMed
    Score: 0.006
  27. Rapid accumulation of endogenous tau oligomers in a rat model of traumatic brain injury: possible link between traumatic brain injury and sporadic tauopathies. J Biol Chem. 2013 Jun 07; 288(23):17042-17050.
    View in: PubMed
    Score: 0.006
  28. Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau. Sci Rep. 2012; 2:700.
    View in: PubMed
    Score: 0.006
  29. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012 Apr; 8(4):445-544.
    View in: PubMed
    Score: 0.006
  30. Glycerol hypersensitivity in a Drosophila model for glycerol kinase deficiency is affected by mutations in eye pigmentation genes. PLoS One. 2012; 7(3):e31779.
    View in: PubMed
    Score: 0.006
  31. Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model. PLoS Genet. 2011 Feb 03; 7(2):e1001288.
    View in: PubMed
    Score: 0.005
  32. Therapeutic removal of amyloid deposits in cutaneous amyloidosis by localised intra-lesional injections of anti-amyloid antibodies. Exp Dermatol. 2010 Oct; 19(10):904-11.
    View in: PubMed
    Score: 0.005
  33. Inhaled insulin forms toxic pulmonary amyloid aggregates. Endocrinology. 2010 Oct; 151(10):4717-24.
    View in: PubMed
    Score: 0.005
  34. New vaccine development for chronic brain disease. Neuropsychopharmacology. 2010 Jan; 35(1):354.
    View in: PubMed
    Score: 0.005
  35. Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein. J Neurosci. 2009 Feb 18; 29(7):1962-76.
    View in: PubMed
    Score: 0.005
  36. Normal-repeat-length polyglutamine peptides accelerate aggregation nucleation and cytotoxicity of expanded polyglutamine proteins. Proc Natl Acad Sci U S A. 2006 Sep 26; 103(39):14367-72.
    View in: PubMed
    Score: 0.004
  37. Hydrolethalus syndrome is caused by a missense mutation in a novel gene HYLS1. Hum Mol Genet. 2005 Jun 01; 14(11):1475-88.
    View in: PubMed
    Score: 0.003
  38. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature. 2001 Oct 18; 413(6857):739-43.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.